GlassScriptPhysician profile
Rachel Janssen
NPI 1235851130
$1,164.63
in general payments reported to CMS, 2019-2025
32 companies · $725 in 2025
The $725 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.69 · 2024: $420 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $136.19 | 2025 | |
| Lilly USA, LLC | $128.35 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $113.33 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Biogen, INC. | $77.68 | 2024-2025 | Zurzuvae |
| Amgen INC. | $76.35 | 2024-2025 | Repatha, Otezla, Otezla |
| Kowa Pharmaceuticals America, INC. | $71.51 | 2025 | Zoryve |
| Nevro Corp. | $43.42 | 2024 | Senza |
| Pfizer INC. | $40.60 | 2024-2025 | |
| Seqirus USA INC | $35.60 | 2024 | Fluad, Flucelvax |
| Sanofi Pasteur INC. | $33.40 | 2025 | |
| Vertical Pharmaceuticals, LLC | $30.17 | 2025 | Relexxii |
| Boston Scientific Corporation | $24.26 | 2024 | |
| Noven Therapeutics, LLC | $23.34 | 2024 | Xelstrym |
| Kyowa Kirin, INC. | $22.60 | 2025 | |
| Alexion Pharmaceuticals, INC. | $22.36 | 2025 | Strensiq |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $21.38 | 2024 | Ycanth |
| Procept Biorobotics Corporation | $20.98 | 2024 | Aquabeam System |
| Corium, LLC | $19.76 | 2024 | Azstarys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.69 | 2021 | |
| Collegium Pharmaceutical, INC. | $18.68 | 2025 | Jornay Pm |
| Hologic Sales and Service, LLC | $17.46 | 2024 | Thinprep 2000 Processor, Aptima |
| Inspire Medical Systems, INC. | $17.37 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $16.79 | 2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Ultragenyx Pharmaceutical INC. | $16.57 | 2025 | Dojolvi |
| Supernus Pharmaceuticals, INC. | $16.26 | 2025 | Qelbree |
| Phathom Pharmaceuticals, INC. | $15.79 | 2024 | Voquezna |
| Cranial Technologies, INC | $14.82 | 2025 | Doc Band |
| Exact Sciences Corporation | $14.65 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $14.53 | 2025 | Vpriv |
| Otsuka America Pharmaceutical, INC. | $13.91 | 2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $13.68 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.15 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Janssen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.